Navigation Links
Teens as Cardiologists in Training: Program Swaps Backpacks for Stethoscopes
Date:6/15/2009

Experts from Northwestern Memorial's Bluhm Cardiovascular Institute open their doors to expose young women to careers in heart medicine and surgery

CHICAGO, June 15 /PRNewswire-USNewswire/ -- Victoria Horsley is like most teenaged girls looking forward to their senior year of high school. Though for her, learning the intricacies of the human heart as part of the Cardiology Summer Academy (CSA) at Northwestern Memorial Hospital's Bluhm Cardiovascular Institute will rank high along with going to prom as one of her favorite senior-year milestones. Horsley is one of 16 returning seniors, from the Young Women's Leadership Academy Charter School of Chicago, selected for the inaugural program's week-long camp.

"I was really intrigued by this program because I've known for a while that I want to be a doctor," says the 16-year-old who brims with excitement about being a part of the program. "When I found out that we would be doing so many hands-on activities, I was even more excited about going, and I was really happy when I found out I was chosen to attend."

Recent statistics from the National Science Foundation show that women make up 44 percent of the U.S. labor force, yet only 26 percent of the nation's scientists and engineers. In an effort to entice more girls to choose careers in medicine and science -- one student at a time -- the Institute for Women's Health Research at Northwestern University's Feinberg School of Medicine has created the Women's Health Science Program (WHSP), and this is the first summer they've partnered with the Bluhm Institute to offer the CSA. The program is led by Northwestern physicians and researchers who will immerse the young women in a medical school-like environment to help them learn about heart disease treatment and prevention.

"Many times a career path is shaped when someone takes a specific interest in an individual," comment
'/>"/>

SOURCE Northwestern Memorial Hospital
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Medical, Insurance, Automotive and Safety Groups Call on Congress to Make This the "Last Deadly Summer for Teens" by Swiftly Passing Federal Teen Driving Safety Bill
2. Recent smoking-cessation research highlights importance of keeping teens from smoking
3. New Program May Help Teens at High Risk for Depression
4. Cervical Cancer Vaccine Not Just for Teens
5. Overweight male teens with normal blood pressures showing signs of heart damage
6. Teens Likely to Trade Team Sports for Individual Exercise
7. Technology, Caffeine Keeping Teens Awake
8. Stigma Keeps Teens From Depression Treatment
9. Use science to convince teens a sober prom is better, AAAS says
10. Rainbow Babies & Childrens Hospitals Use It or Lose It High School Seat Belt Challenge Brings Out the Creativity in Cuyahoga County Teens
11. Parents Influence Sex Decisions, Hispanic Teens Say

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... HealthSmart, an innovative healthcare benefit...ccessfully completed a recapitalization with Silve...r lenders. Silver Point Capital, L.P. is a privat... This recapitalization allows the Company to cont...y. , , (PRWEB) November ...
(Date:11/21/2009)...N, Nov. 21 Tonight, in ...to Senator Reid,s version of the government takeov... items included in this bill; like the public opti...nment funding for elective abortion, which is the ...ly the bill provides subsidies for private plans t...
(Date:11/21/2009)...ON, Nov. 21 A regional ...ocerciasis (river blindness) in the Americas has s... in recent years, as evidenced by a 31% decrease i...ministration in six endemic countries. Results we...e American Society of Tropical Medicine and Hygien...
(Date:11/21/2009)... Innovative medical apparel company launches m... San Clemente, Calif. (PRWEB) Nov...ough medical apparel, today announced the launch o...ica 2009, a leading international trade fair for t...edelita inaugurates its men,s collection with thre...
(Date:11/21/2009)... Linwood Group ask whether there is a secret t... , London, UK (PRWEB) Nove... to one in three of the adult UK population drinki...lcohol-related liver disease*, it is hardly a surp...itation programmes and residential centres for hel...
Breaking Medicine News(10 mins):Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4
...y, ALLEGAN, Mich., May 21 Perrigo Company,(Nasda...ed into a,collaborative agreement with Cobrek Phar...maceuticals Inc., a privately owned company that s... foam, a $34,million branded pharmaceutical produc...
.... (NYSE: CNO ) at the company,s annual meeting to...expiring at next year,s annual meeting;, -- A... incorporation to eliminate the plurality voti...LP as the company,s independent registered pub...
...have identified a biological explanation for the l...allergy and asthma in childhood. They will present...2008 International Conference in Toronto on Tuesda...d cord blood levels of IL-13, a Th2 type cytokine,...
...d: CRDT), a leading healthcare staffing company, h...arch 31, 2008., Revenue in the quarter was $10,57...revenue of $9,806,540 and an increase of 31% over ...urth quarter of 2007 and $1,712,150 in the first q...
... in very young children may cause some of the adve...er children and adults with the condition, accordi...r findings at the American Thoracic Societys 2008 ...st and sleep specialist who led the study at Ben-G...
...turer,of laser and light-based skin sculpting and ...he introduction of an additional fractional,device...s two new features,-- significantly higher speed, ...aster than competitive instruments, ProFractional-...
Other Medicine News:Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 2Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 3Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 4Health News:Possible biological explanation for C-Section-linked allergies and asthma found 2Health News:Crdentia Announces 2008 First Quarter Results 2Health News:Crdentia Announces 2008 First Quarter Results 3Health News:Crdentia Announces 2008 First Quarter Results 4Health News:Crdentia Announces 2008 First Quarter Results 5Health News:Crdentia Announces 2008 First Quarter Results 6Health News:Crdentia Announces 2008 First Quarter Results 7Health News:Sciton Introduces ProFractional-XC(TM), High-Speed, Dual-Mode Fractional Laser 2
(Date:11/20/2009)..., MINNEAPOLIS, Nov. 20 B...sults for its first quarter ended September 30, 20...uted share, on revenues of $3,263,000. This compa...ted share, on revenues of $3,168,000 for the first...st quarter results, Biotel President and CEO Steve...
(Date:11/20/2009)... , PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire-U...mes article that questions why currently availabl...ancers are being ignored, ECRI Institute, an indep...ap to the evidence on Finasteride for Prevention ... November 13, 2009, New York Times article, " Dr...
(Date:11/20/2009)..., MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCall/...s Division is pleased to announce the signing of a...tates Department of Defense that may lead to the c...revolutionize the treatment of the limbs of soldie...ar, the Defense Advanced Research Projects Agency ...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Proposal to reintroduce Iberian lynx on abandoned agricultural land 57527 1Proposal to reintroduce Iberian lynx on abandoned agricultural land 57527 2National new biology initiative offers potential for remarkable and far reaching benefits 9968 1National new biology initiative offers potential for remarkable and far reaching benefits 9968 2National new biology initiative offers potential for remarkable and far reaching benefits 9968 3The Vitality Group Joins Efforts to Improve Health of U S Workforce 57525 1The Vitality Group Joins Efforts to Improve Health of U S Workforce 57525 2
...nation with CRESTOR (rosuvastatin calcium) Improv...ety Consistent with Monotherap...hat in patients with multiple lipid problems, Abbo...ed with AstraZeneca,s CRESTOR(R) (rosuvastatin,cal...onding monotherapy in,treating all three key lipid...
...Data Reported Trial Enrollment Advanc...., May 31 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ...from the company,s ongoing Phase 2 clinical trial ... SNS-595), in platinum-resistant ovarian,cancer pa...cology (ASCO),Annual Meeting in Chicago, Illinois....
Other Medicine Technology:Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 2Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 3Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5
Prechopper curved
Medina Irrigating Nucleus Chopper
Rosen Irrigating Nucleus Chopper
Agarwal Irrigating Nucleus Chopper
Medicine Products: